PDK1 and breast carcinoma: A small number of recent studies have linked aspirin’s anti-cancer effects to metabolism; aspirin has been found to inhibit glucose metabolism through the regulation of PDK1 in breast cancer cells [50] and through the regulation of GLUT1 in hepatoma cells [51].